Bharat Biotech completes enrollment of 25,800 volunteers for Covaxin Phase-3 trials
Hyderabad: Bharat Biotech has completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin. This information ...
Read moreDetails